CY1113500T1 - Συστημα χορηγησης φαρμακου - Google Patents
Συστημα χορηγησης φαρμακουInfo
- Publication number
- CY1113500T1 CY1113500T1 CY20121101258T CY121101258T CY1113500T1 CY 1113500 T1 CY1113500 T1 CY 1113500T1 CY 20121101258 T CY20121101258 T CY 20121101258T CY 121101258 T CY121101258 T CY 121101258T CY 1113500 T1 CY1113500 T1 CY 1113500T1
- Authority
- CY
- Cyprus
- Prior art keywords
- loaded
- thermoplastic polymer
- drug
- administration system
- medicine administration
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/34—Gestagens
Abstract
Η προκείμενη εφεύρεση προβλέπει σύστημα χορήγησης φαρμάκου που περιλαμβάνει ένα τουλάχιστον διαμέρισμα, αποτελούμενο από (i) έναν πυρήνα θερμοπλαστικού πολυμερούς φορτωμένο με φάρμακο, (ii) ένα ενδιάμεσο στρώμα θερμοπλαστικού πολυμερούς φορτωμένο με φάρμακο και (iii) ένα μη φαρμακευτικό περίβλημα θερμοπλαστικού πολυμερούς που καλύπτει το ενδιάμεσο στρώμα, όπου το προαναφερόμενο ενδιάμεσο στρώμα είναι φορτωμένο με (α) κρυστάλλους μιας πρώτης φαρμακευτικά δραστικής ένωσης και με (β) κάποια δεύτερη φαρμακευτικά δραστική ένωση σε διαλυτοποιημένη μορφή και όπου ο προαναφερόμενος πυρήνας είναι φορτωμένος με την προαναφερόμενη δεύτερη ένωση σε διαλυτοποιημένη μορφή.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US47305503P | 2003-05-23 | 2003-05-23 | |
EP03101490 | 2003-05-23 | ||
EP04741599A EP1631255B1 (en) | 2003-05-23 | 2004-05-19 | Drug delivery system |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1113500T1 true CY1113500T1 (el) | 2016-06-22 |
Family
ID=36701594
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20121101258T CY1113500T1 (el) | 2003-05-23 | 2012-12-21 | Συστημα χορηγησης φαρμακου |
Country Status (30)
Country | Link |
---|---|
US (3) | US8333983B2 (el) |
EP (1) | EP1631255B1 (el) |
JP (1) | JP4685780B2 (el) |
KR (1) | KR101116267B1 (el) |
CN (1) | CN1794974B (el) |
AR (1) | AR044547A1 (el) |
AU (1) | AU2004241747B2 (el) |
BR (1) | BRPI0410455B8 (el) |
CA (1) | CA2524665C (el) |
CO (1) | CO5630021A2 (el) |
CY (1) | CY1113500T1 (el) |
DK (1) | DK1631255T3 (el) |
EC (1) | ECSP056250A (el) |
ES (1) | ES2396100T3 (el) |
HK (1) | HK1084337A1 (el) |
HR (1) | HRP20050945B1 (el) |
IL (1) | IL171622A (el) |
IS (1) | IS2864B (el) |
MX (1) | MXPA05012595A (el) |
NO (1) | NO336456B1 (el) |
NZ (1) | NZ543652A (el) |
PE (1) | PE20050815A1 (el) |
PL (1) | PL1631255T3 (el) |
PT (1) | PT1631255E (el) |
RU (1) | RU2340344C2 (el) |
SI (1) | SI1631255T1 (el) |
TW (1) | TWI336627B (el) |
UA (1) | UA84287C2 (el) |
WO (1) | WO2004103336A2 (el) |
ZA (1) | ZA200509450B (el) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8110211B2 (en) * | 2004-09-22 | 2012-02-07 | Advanced Cardiovascular Systems, Inc. | Medicated coatings for implantable medical devices including polyacrylates |
US8703167B2 (en) * | 2006-06-05 | 2014-04-22 | Advanced Cardiovascular Systems, Inc. | Coatings for implantable medical devices for controlled release of a hydrophilic drug and a hydrophobic drug |
UA94118C2 (ru) | 2006-11-20 | 2011-04-11 | Н.В. Органон | Спиральная система введения лекарства |
JP2010510290A (ja) * | 2006-11-22 | 2010-04-02 | ナームローゼ・フエンノートチヤツプ・オルガノン | ミルタザピンのための膣送達系 |
TW200930343A (en) * | 2007-09-21 | 2009-07-16 | Organon Nv | Drug delivery system |
EP2062568A1 (en) * | 2007-11-22 | 2009-05-27 | Bayer Schering Pharma Oy | Vaginal delivery system |
WO2009141309A1 (en) * | 2008-05-20 | 2009-11-26 | N.V. Organon | Delivery system for paliperidone |
ES2344673B1 (es) * | 2008-08-07 | 2011-05-03 | Italfarmaco, S.A. | Uso de estriol en la preparacion de una formulacion farmaceutica parael tratamiento de atrofia vaginal en mujeres con riesgo de potologiatumoral. |
FI121000B (fi) * | 2008-11-19 | 2010-06-15 | Bayer Schering Pharma Oy | Intravaginaalinen antojärjestelmä ja menetelmä sen valmistamiseksi |
WO2010077096A2 (ko) * | 2008-12-31 | 2010-07-08 | 한올바이오파마주식회사 | 약물전달기구 |
WO2010105995A2 (en) | 2009-03-17 | 2010-09-23 | Intervet International B.V. | Zoo-technical drug delivery device |
BR112012001353B8 (pt) * | 2009-07-21 | 2021-05-25 | The Population Council Inc | anel vaginal, e, método para fabricar um anel vaginal |
CA2798034A1 (en) * | 2010-03-28 | 2011-10-13 | Evestra, Inc. | Intravaginal drug delivery device |
US8580294B2 (en) | 2010-10-19 | 2013-11-12 | International Partnership For Microbicides | Platinum-catalyzed intravaginal rings |
AU2012283837B2 (en) * | 2011-07-20 | 2017-04-27 | Patrick F. Kiser | Intravaginal devices for drug delivery |
HRP20211377T1 (hr) | 2011-11-23 | 2022-01-07 | Therapeuticsmd, Inc. | Prirodne kombinirane hormonske supstitucijske formulacije i terapije |
US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10137031B2 (en) | 2013-11-14 | 2018-11-27 | International Partnership For Microbicides, Inc. | Combination therapy intravaginal rings |
WO2015086489A1 (en) | 2013-12-11 | 2015-06-18 | Merck Sharp & Dohme B.V. | Drug delivery system for delivery of anti-virals |
US10413504B2 (en) * | 2013-12-11 | 2019-09-17 | Merck Sharp & Dohme Corp. | Intravaginal ring drug delivery system |
RU2016143081A (ru) | 2014-05-22 | 2018-06-26 | Терапьютиксмд, Инк. | Натуральные комбинированные гормонозаместительные составы и терапии |
US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
WO2017173044A1 (en) | 2016-04-01 | 2017-10-05 | Therapeuticsmd Inc. | Steroid hormone compositions in medium chain oils |
AU2017239645A1 (en) | 2016-04-01 | 2018-10-18 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical composition |
CN109069526A (zh) * | 2016-05-12 | 2018-12-21 | 默沙东公司 | 用于递送抗病毒剂的药物递送系统 |
US10406336B2 (en) | 2016-08-03 | 2019-09-10 | Neil S. Davey | Adjustable rate drug delivery implantable device |
CA3080325A1 (en) | 2017-10-27 | 2019-05-02 | Renovia Inc. | Devices, systems, and methods for training pelvic floor muscles |
US11690806B2 (en) | 2018-05-24 | 2023-07-04 | Celanese Eva Performance Polymers Llc | Implantable device for sustained release of a macromolecular drug compound |
SG11202005947RA (en) | 2018-05-24 | 2020-07-29 | Celanese Eva Performance Polymers Corp | Implantable device for sustained release of a macromolecular drug compound |
US20200179274A1 (en) * | 2018-12-11 | 2020-06-11 | Lupin Inc. | Drug delivery system for ultra-low dose estrogen combinations and methods and uses thereof |
KR102159904B1 (ko) | 2020-04-24 | 2020-09-24 | 강경원 | 약물 방출 고리를 구비한 월경컵 |
EP4215181A1 (en) * | 2022-01-21 | 2023-07-26 | Sever Pharma Solutions | An intravaginal ring |
WO2023200974A1 (en) * | 2022-04-14 | 2023-10-19 | Yale University | Nanoparticles and nanoparticle-releasing vaginal rings |
WO2024030116A1 (en) * | 2022-08-01 | 2024-02-08 | Lupin Inc. | Drug delivery system for ultra-low dose estrogen combinations and methods and uses thereof |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3545439A (en) * | 1968-01-04 | 1970-12-08 | Upjohn Co | Medicated devices and methods |
US3854480A (en) * | 1969-04-01 | 1974-12-17 | Alza Corp | Drug-delivery system |
US3995634A (en) | 1975-12-02 | 1976-12-07 | The Procter & Gamble Company | Vaginal cavity dispensing means and method |
US3995633A (en) | 1975-12-02 | 1976-12-07 | The Procter & Gamble Company | Vaginal Medicament dispensing device |
US4237885A (en) | 1978-10-23 | 1980-12-09 | Alza Corporation | Delivery system with mated members for storing and releasing a plurality of beneficial agents |
US4292965A (en) * | 1978-12-29 | 1981-10-06 | The Population Council, Inc. | Intravaginal ring |
DE3040978A1 (de) | 1980-10-28 | 1982-05-27 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Vaginalring |
US4629449A (en) * | 1982-07-29 | 1986-12-16 | Alza Corporation | Vaginal dispenser for dispensing beneficial hormone |
EP0162492B1 (en) * | 1984-04-11 | 1989-08-02 | Thiemann Arzneimittel GmbH | Dosage units for controlled release of active material |
US4596576A (en) | 1984-10-12 | 1986-06-24 | Akzo N.V. | Release system for two or more active substances |
DE19975054I2 (de) | 1987-08-08 | 2000-04-13 | Akzo Nobel Nv | Kontrazeptives Implantat |
US5766632A (en) * | 1993-10-01 | 1998-06-16 | Legere Pharmaceuticals, Ltd. | Method of using lectins for contraception |
JP3720386B2 (ja) * | 1993-12-27 | 2005-11-24 | 住友製薬株式会社 | 薬物放出制御製剤 |
EP0836473B1 (en) | 1995-07-04 | 2001-10-31 | Akzo Nobel N.V. | Ring-shaped devices |
US5972372A (en) | 1996-07-31 | 1999-10-26 | The Population Council, Inc. | Intravaginal rings with insertable drug-containing core |
IL123813A0 (en) * | 1997-04-11 | 1998-10-30 | Akzo Nobel Nv | Drug delivery system for two or more active substances |
DE69817017T2 (de) | 1997-12-12 | 2004-02-26 | Akzo Nobel N.V. | Verpackung für einen vaginalring |
US6579533B1 (en) * | 1999-11-30 | 2003-06-17 | Bioasborbable Concepts, Ltd. | Bioabsorbable drug delivery system for local treatment and prevention of infections |
CA2442281C (en) * | 2001-03-27 | 2010-06-08 | Galen (Chemicals) Limited | Intravaginal drug delivery devices for the administration of an antimicrobial agent |
WO2003000156A1 (en) * | 2001-06-22 | 2003-01-03 | Southern Biosystems, Inc. | Zero-order prolonged release coaxial implants |
PL367961A1 (en) * | 2001-08-31 | 2005-03-07 | Schering Oy | Drug delivery system |
-
2004
- 2004-05-03 TW TW093112401A patent/TWI336627B/zh not_active IP Right Cessation
- 2004-05-19 KR KR1020057022407A patent/KR101116267B1/ko active IP Right Grant
- 2004-05-19 CN CN2004800142223A patent/CN1794974B/zh active Active
- 2004-05-19 AU AU2004241747A patent/AU2004241747B2/en active Active
- 2004-05-19 NZ NZ543652A patent/NZ543652A/en not_active IP Right Cessation
- 2004-05-19 MX MXPA05012595A patent/MXPA05012595A/es active IP Right Grant
- 2004-05-19 US US10/558,040 patent/US8333983B2/en active Active
- 2004-05-19 WO PCT/EP2004/050850 patent/WO2004103336A2/en active Application Filing
- 2004-05-19 RU RU2005140277/15A patent/RU2340344C2/ru active
- 2004-05-19 ES ES04741599T patent/ES2396100T3/es active Active
- 2004-05-19 DK DK04741599.7T patent/DK1631255T3/da active
- 2004-05-19 SI SI200431986T patent/SI1631255T1/sl unknown
- 2004-05-19 EP EP04741599A patent/EP1631255B1/en active Active
- 2004-05-19 PL PL04741599T patent/PL1631255T3/pl unknown
- 2004-05-19 JP JP2006530206A patent/JP4685780B2/ja active Active
- 2004-05-19 CA CA2524665A patent/CA2524665C/en active Active
- 2004-05-19 PT PT47415997T patent/PT1631255E/pt unknown
- 2004-05-19 BR BRPI0410455A patent/BRPI0410455B8/pt active IP Right Grant
- 2004-05-19 UA UAA200510424A patent/UA84287C2/uk unknown
- 2004-05-21 AR ARP040101763A patent/AR044547A1/es not_active Application Discontinuation
- 2004-05-21 PE PE2004000522A patent/PE20050815A1/es not_active Application Discontinuation
-
2005
- 2005-10-24 IS IS8086A patent/IS2864B/is unknown
- 2005-10-27 IL IL171622A patent/IL171622A/en not_active IP Right Cessation
- 2005-11-03 NO NO20055171A patent/NO336456B1/no not_active IP Right Cessation
- 2005-11-04 HR HRP20050945AA patent/HRP20050945B1/hr not_active IP Right Cessation
- 2005-11-18 CO CO05117347A patent/CO5630021A2/es active IP Right Grant
- 2005-11-22 ZA ZA200509450A patent/ZA200509450B/en unknown
- 2005-12-23 EC EC2005006250A patent/ECSP056250A/es unknown
-
2006
- 2006-06-12 HK HK06106692.2A patent/HK1084337A1/xx not_active IP Right Cessation
-
2012
- 2012-11-09 US US13/672,804 patent/US8900615B2/en active Active
- 2012-11-09 US US13/673,162 patent/US8858977B2/en active Active
- 2012-12-21 CY CY20121101258T patent/CY1113500T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1113500T1 (el) | Συστημα χορηγησης φαρμακου | |
CY1105690T1 (el) | Μεθοδοι και σκευασματα για χορηγηση ταξανιων | |
CY1116429T1 (el) | Υμενιο για δερματικη και διαδερμικη χορηγηση δραστικων συστατικων | |
CY1106834T1 (el) | Διαδερμικο επιθεμα για τη χορηγηση φεντανιλ | |
ATE426635T1 (de) | Arzneimittelverabreichung | |
AR033903A1 (es) | Una composicion de insulina modificada quimicamente para la administracion pulmonar | |
DE60233944D1 (de) | Wirkstoffabgabesysteme | |
BR0102040A (pt) | Uso de paclitaxel estabilizado com albumina para preparação de uma droga para o tratamento de tumores sólidos e a droga desse modo obtida | |
BRPI0406486A (pt) | Dispositivo de administração para medicamento fluido | |
MY163892A (en) | Drug delivery system | |
SE0003449D0 (sv) | Anticancer compositions | |
EE05506B1 (et) | Ravimi manustamise vahend eriti progestiinide jastrogeenide manustamiseks | |
CY1105795T1 (el) | Σκευασματα για βελτιωση της βιοδιαθεσιμοτητας χορηγουμενων απο το στομα φαρμακων | |
EA200401252A1 (ru) | Микрочастицы лекарственных веществ | |
ES2272768T3 (es) | Composiciones para la administracion de combinaciones de farmacos. | |
DK1392254T3 (da) | Micelle-lægemiddelindgivelsessystem for hydrofobe lægemidler | |
AR025449A1 (es) | Soluciones farmaceuticas de levosimendan | |
CY1108016T1 (el) | Βελτιωσεις σε διαταξεις χορηγησεως φαρμακου | |
CY1108362T1 (el) | Διαταξη παροχης φαρμακου που ειναι ευδιακριτη με τις ακτινες χ | |
CY1115064T1 (el) | Διαδερμικο συστημα παραδοσης ορμονων χωρις ενισχυτες διεισδυσης | |
UY28057A1 (es) | Formulacion y forma de dosificacion que provee mayor biodisponibilidad de los farmacos hidrófobos | |
TR200102939T2 (tr) | Farmasötik bileşikler | |
CY1105464T1 (el) | Διαλυμα ενος αντιβιοτικου φαρμακου οξαζολιδινονης | |
EE05415B1 (et) | Ravimi manustamise vahend, eriti androgeenide manustamiseks | |
CY1106964T1 (el) | Φαρμακα που περιεχουν ν,ν’-διυποκατεστημενες ενωσεις πιπεραζινης και η χρησιμοποιηση τους |